Biotech Industry Examiner

Menu
Menu
subscribe now
Search
From Cow-Free Dairy to Human Milk 2.0: Biotechs Race to Brew Breast Milk Proteins

From Cow-Free Dairy to Human Milk 2.0: Biotechs Race to Brew Breast Milk Proteins

The first wave of “milk without cows” promised more sustainable

Texas Ban on Lab-Grown Meat Triggers Policy and Legal Showdowns

Texas Ban on Lab-Grown Meat Triggers Policy and Legal Showdowns

A State-Level Ban in the Lone Star State In a

Tropic Unveils Gene-Edited Non-Browning Bananas to Reduce Food Waste

Tropic Unveils Gene-Edited Non-Browning Bananas to Reduce Food Waste

A New Era for Bananas: The Innovation That Could Change

Revolutionizing Dairy: How Biotech Companies are Producing Milk Without Cows

Revolutionizing Dairy: How Biotech Companies are Producing Milk Without Cows

Abstract This report explores the emerging field of animal-free dairy

Sanofi’s $2.2bn Dynavax deal — and the quiet power of adult vaccines

Sanofi’s $2.2bn Dynavax deal — and the quiet power of adult vaccines

The GLP-1 pill arrives: Novo’s oral Wegovy reshapes the obesity market

The GLP-1 pill arrives: Novo’s oral Wegovy reshapes the obesity market

Chai Discovery’s $130m bet: can “CAD for molecules” make biologics faster and cheaper?

Chai Discovery’s $130m bet: can “CAD for molecules” make biologics faster and cheaper?

From Cow-Free Dairy to Human Milk 2.0: Biotechs Race to Brew Breast Milk Proteins

From Cow-Free Dairy to Human Milk 2.0: Biotechs Race to Brew Breast Milk Proteins

When the FDA Starts Trusting Algorithms: What AIM-NASH Means for Liver Drug Trials

When the FDA Starts Trusting Algorithms: What AIM-NASH Means for Liver Drug Trials

MOST POPULAR

News

The GLP-1 pill arrives: Novo’s oral Wegovy reshapes the obesity market
The obesity wars go to court: Pfizer says Novo’s Metsera bid is a moat, not a merger
Galapagos quits cell therapy. Europe’s CGT reckoning begins.
Dermatology’s next play: bispecifics that shut down OX40L and TNF

Funding

Aging Science

The explainable aging clock regulators might actually like
Impact of Space Travel on Immune Function and Potential Countermeasures
Debate Highlights: Can Aging Be Halted or Reversed? Experts Weigh In
Epigenetic Stability Linked to Lifespan in Mammals, Research Show

Genomics

M&A & Partnerships

Sanofi’s $2.2bn Dynavax deal — and the quiet power of adult vaccines
Pfizer’s $4.9bn Metsera bet: can amylin finally tame GLP-1’s ‘GI tax’?
More Than a Shot: Sanofi’s Vicebio Deal Shows the Power of Platform Biotech
Roche’s Bold Foray into Obesity Treatment: A $5.3 Billion Bet on Petrelintide

Biotech Stocks

Psychology

Innovative Study on Addiction by Mount Sinai and Rockefeller University

Copyright © Industry Examiner 2025 . All rights reserved.

Industry Examiner LLC 166 Geary St. STE 1500 #2640, San Francisco, CA 94108

Facebook Twitter Linkedin Link
Scroll to Top